Skip to main content

letter

. 1988 Apr 30;296(6631):1262–1263. doi: 10.1136/bmj.296.6631.1262-c

Drug points: Gynaecomastia associated with captopril

H M Markusse, R H B Meyboom

PMCID: PMC2545690 PMID: 3133043

1262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Edwards I. R., Coulter D. M., Beasley D. M., MacIntosh D. Captopril: 4 years of post marketing surveillance of all patients in New Zealand. Br J Clin Pharmacol. 1987 May;23(5):529–536. doi: 10.1111/j.1365-2125.1987.tb03088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kahl L. E., Medsger T. A., Jr, Klein I. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. J Rheumatol. 1985 Oct;12(5):990–991. [PubMed] [Google Scholar]
Reid D. M., Martynoga A. G., Nuki G. Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) 1982 Oct 16;285(6348):1083–1084. doi: 10.1136/bmj.285.6348.1083-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES